Browse
Drugs
Categories
Pathways
Drug Reactions
Drug Classification
Drug Targets
Pharmaco-genomics
Pharmaco-metabolomics
Pharmaco-transcriptomics
Pharmaco-proteomics
Search
Chemical Structure
Molecular Weight
Drug & Food Interactions
Target Sequences
Pharmaco-omics
Advanced Search
MS Search
MS/MS Search
GC/MS Search
1D NMR Search
2D NMR Search
Downloads
About
About DrugBank
Statistics
Other Databases
Data Sources
News Archive
Wishart Research Group
Help
Citing DrugBank
Help Center
FAQ
Searching DrugBank
Blog
Contact Us

Oral Oxycodone With/Without Naloxone

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB01183	Naloxone	4	Completed	1
DB00497	Oxycodone	4	Completed	1

About

About DrugBank
DrugBank Blog
Wishart Research Group
Terms of Use
Privacy Policy

Support

FAQ
Help Center
Email Support

Commercial Products

API Pricing
API Docs
Data Licenses
Support

This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with funding from the federal government. Maintenance, support, and commercial licensing is provided by OMx Personal Health Analytics, Inc. Designed by Educe Design & Innovation Inc.